Finerenone + empagliflozin

  • 1 lab in 1 country
  • Funders: Jiangxi Provincial Natural Science Foundation and 2 more

Associations

1

Hyperkalaemia

upin humans1RR 2.48

1 study
  1. Finerenone + empagliflozin raises the risk of hyperkalaemia in humans (RR 2.48, 95% CI: 1.22-5.06).

    Reviewcompared with empagliflozin alone

    Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease

    Diabetes, obesity & metabolism17 Sep 2026

More on Hyperkalaemia

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01 in 12 months